Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer

Gynecologic Oncology
Kevin H EngJ Brian Szender

Abstract

The presence of miliary disease during initial ovarian cancer debulking may reflect a distinct mode of peritoneal spread independent from size-based tumor staging and may explain variation in response to treatment and survival outcomes. To infer the prevalence, presentation and clinical implications of miliary disease we reviewed existing surgical records. Reports were available for 1008 primary debulking surgeries for ovarian, primary peritoneal or fallopian tube cancer between 2001 and 2015 (685 reports from 2005 to 2015). Clinical outcome data was available for 938 patients. We analyzed a high-stage sub-cohort for survival (N=436). Most records were evaluable for miliary disease (761/938); for these, the miliary phenotype was highly prevalent (249/761, 32.7%) and often accompanied by ascites (185/249, 74%). While optimal debulking rates were unaffected by miliary disease, total resection (R0) rates were poorer. Liver, stomach, spleen or bladder appeared to be sporadically involved while the omentum, mesentery, bowel, peritoneum and diaphragm were affected simultaneously (Spearman rho>0.5). Overall, miliary disease was associated with worse progression free survival, overall survival, and time from relapse to death independen...Continue Reading

References

Aug 1, 2006·Gynecologic Oncology·Scott M EisenkopWei-Chien Michael Lin
Sep 20, 2008·American Journal of Obstetrics and Gynecology·Anna FagottiGiovanni Scambia
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 23, 2010·World Journal of Surgical Oncology·Azam-Sadat MousaviSetareh Akhavan
Sep 8, 2010·The New England Journal of Medicine·Ignace VergoteUNKNOWN NCIC Clinical Trials Group
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Siriwan TangjitgamolAndrew Bryant
Aug 13, 2011·The Cochrane Database of Systematic Reviews·Ahmed ElattarRaj Naik
Jul 31, 2013·American Journal of Obstetrics and Gynecology·Anna FagottiGiovanni Scambia
Nov 14, 2013·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jaime Prat, UNKNOWN FIGO Committee on Gynecologic Oncology
Nov 14, 2014·Wiener medizinische Wochenschrift·Stefanie Aust, Dietmar Pils
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil S HorowitzG Larry Maxwell
Feb 25, 2015·Nature Reviews. Clinical Oncology·Alpa M NickAnil K Sood
Mar 22, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna FagottiGiovanni Scambia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.